Copyright Reports & Markets. All rights reserved.

Global Brigatinib API Market 2026 by Manufacturers, Regions, Type and Application, Forecast to 2032

Request for Sample of this report
Buy now

1 Market Overview

  • 1.1 Product Overview and Scope
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Market Analysis by Type
    • 1.3.1 Overview: Global Brigatinib API Consumption Value by Type: 2021 Versus 2025 Versus 2032
    • 1.3.2 Purity≥99%
    • 1.3.3 Purity<99%
  • 1.4 Market Analysis by Application
    • 1.4.1 Overview: Global Brigatinib API Consumption Value by Application: 2021 Versus 2025 Versus 2032
    • 1.4.2 Online Sales
    • 1.4.3 Offline Sales
  • 1.5 Global Brigatinib API Market Size & Forecast
    • 1.5.1 Global Brigatinib API Consumption Value (2021 & 2025 & 2032)
    • 1.5.2 Global Brigatinib API Sales Quantity (2021-2032)
    • 1.5.3 Global Brigatinib API Average Price (2021-2032)

2 Manufacturers Profiles

  • 2.1 Dr. Reddy’s Laboratories
    • 2.1.1 Dr. Reddy’s Laboratories Details
    • 2.1.2 Dr. Reddy’s Laboratories Major Business
    • 2.1.3 Dr. Reddy’s Laboratories Brigatinib API Product and Services
    • 2.1.4 Dr. Reddy’s Laboratories Brigatinib API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.1.5 Dr. Reddy’s Laboratories Recent Developments/Updates
  • 2.2 Vitasv Pharma And Chemical
    • 2.2.1 Vitasv Pharma And Chemical Details
    • 2.2.2 Vitasv Pharma And Chemical Major Business
    • 2.2.3 Vitasv Pharma And Chemical Brigatinib API Product and Services
    • 2.2.4 Vitasv Pharma And Chemical Brigatinib API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.2.5 Vitasv Pharma And Chemical Recent Developments/Updates
  • 2.3 LGC
    • 2.3.1 LGC Details
    • 2.3.2 LGC Major Business
    • 2.3.3 LGC Brigatinib API Product and Services
    • 2.3.4 LGC Brigatinib API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.3.5 LGC Recent Developments/Updates
  • 2.4 Cayman Chemical
    • 2.4.1 Cayman Chemical Details
    • 2.4.2 Cayman Chemical Major Business
    • 2.4.3 Cayman Chemical Brigatinib API Product and Services
    • 2.4.4 Cayman Chemical Brigatinib API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.4.5 Cayman Chemical Recent Developments/Updates
  • 2.5 Conscientia Industrial
    • 2.5.1 Conscientia Industrial Details
    • 2.5.2 Conscientia Industrial Major Business
    • 2.5.3 Conscientia Industrial Brigatinib API Product and Services
    • 2.5.4 Conscientia Industrial Brigatinib API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.5.5 Conscientia Industrial Recent Developments/Updates
  • 2.6 Manus Aktteva Biopharma LLP
    • 2.6.1 Manus Aktteva Biopharma LLP Details
    • 2.6.2 Manus Aktteva Biopharma LLP Major Business
    • 2.6.3 Manus Aktteva Biopharma LLP Brigatinib API Product and Services
    • 2.6.4 Manus Aktteva Biopharma LLP Brigatinib API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.6.5 Manus Aktteva Biopharma LLP Recent Developments/Updates
  • 2.7 Selleck
    • 2.7.1 Selleck Details
    • 2.7.2 Selleck Major Business
    • 2.7.3 Selleck Brigatinib API Product and Services
    • 2.7.4 Selleck Brigatinib API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.7.5 Selleck Recent Developments/Updates
  • 2.8 Shandong Sihuan Pharmaceutical
    • 2.8.1 Shandong Sihuan Pharmaceutical Details
    • 2.8.2 Shandong Sihuan Pharmaceutical Major Business
    • 2.8.3 Shandong Sihuan Pharmaceutical Brigatinib API Product and Services
    • 2.8.4 Shandong Sihuan Pharmaceutical Brigatinib API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.8.5 Shandong Sihuan Pharmaceutical Recent Developments/Updates
  • 2.9 Anqing benro Pharmaceutical
    • 2.9.1 Anqing benro Pharmaceutical Details
    • 2.9.2 Anqing benro Pharmaceutical Major Business
    • 2.9.3 Anqing benro Pharmaceutical Brigatinib API Product and Services
    • 2.9.4 Anqing benro Pharmaceutical Brigatinib API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.9.5 Anqing benro Pharmaceutical Recent Developments/Updates
  • 2.10 Vasudha Pharma
    • 2.10.1 Vasudha Pharma Details
    • 2.10.2 Vasudha Pharma Major Business
    • 2.10.3 Vasudha Pharma Brigatinib API Product and Services
    • 2.10.4 Vasudha Pharma Brigatinib API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.10.5 Vasudha Pharma Recent Developments/Updates
  • 2.11 Hefei Home Sunshine Pharmaceutical Technology
    • 2.11.1 Hefei Home Sunshine Pharmaceutical Technology Details
    • 2.11.2 Hefei Home Sunshine Pharmaceutical Technology Major Business
    • 2.11.3 Hefei Home Sunshine Pharmaceutical Technology Brigatinib API Product and Services
    • 2.11.4 Hefei Home Sunshine Pharmaceutical Technology Brigatinib API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.11.5 Hefei Home Sunshine Pharmaceutical Technology Recent Developments/Updates
  • 2.12 Sandoo Pharmaceuticals and Chemicals
    • 2.12.1 Sandoo Pharmaceuticals and Chemicals Details
    • 2.12.2 Sandoo Pharmaceuticals and Chemicals Major Business
    • 2.12.3 Sandoo Pharmaceuticals and Chemicals Brigatinib API Product and Services
    • 2.12.4 Sandoo Pharmaceuticals and Chemicals Brigatinib API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.12.5 Sandoo Pharmaceuticals and Chemicals Recent Developments/Updates

3 Competitive Environment: Brigatinib API by Manufacturer

  • 3.1 Global Brigatinib API Sales Quantity by Manufacturer (2021-2026)
  • 3.2 Global Brigatinib API Revenue by Manufacturer (2021-2026)
  • 3.3 Global Brigatinib API Average Price by Manufacturer (2021-2026)
  • 3.4 Market Share Analysis (2025)
    • 3.4.1 Producer Shipments of Brigatinib API by Manufacturer Revenue ($MM) and Market Share (%): 2025
    • 3.4.2 Top 3 Brigatinib API Manufacturer Market Share in 2025
    • 3.4.3 Top 6 Brigatinib API Manufacturer Market Share in 2025
  • 3.5 Brigatinib API Market: Overall Company Footprint Analysis
    • 3.5.1 Brigatinib API Market: Region Footprint
    • 3.5.2 Brigatinib API Market: Company Product Type Footprint
    • 3.5.3 Brigatinib API Market: Company Product Application Footprint
  • 3.6 New Market Entrants and Barriers to Market Entry
  • 3.7 Mergers, Acquisition, Agreements, and Collaborations

4 Consumption Analysis by Region

  • 4.1 Global Brigatinib API Market Size by Region
    • 4.1.1 Global Brigatinib API Sales Quantity by Region (2021-2032)
    • 4.1.2 Global Brigatinib API Consumption Value by Region (2021-2032)
    • 4.1.3 Global Brigatinib API Average Price by Region (2021-2032)
  • 4.2 North America Brigatinib API Consumption Value (2021-2032)
  • 4.3 Europe Brigatinib API Consumption Value (2021-2032)
  • 4.4 Asia-Pacific Brigatinib API Consumption Value (2021-2032)
  • 4.5 South America Brigatinib API Consumption Value (2021-2032)
  • 4.6 Middle East & Africa Brigatinib API Consumption Value (2021-2032)

5 Market Segment by Type

  • 5.1 Global Brigatinib API Sales Quantity by Type (2021-2032)
  • 5.2 Global Brigatinib API Consumption Value by Type (2021-2032)
  • 5.3 Global Brigatinib API Average Price by Type (2021-2032)

6 Market Segment by Application

  • 6.1 Global Brigatinib API Sales Quantity by Application (2021-2032)
  • 6.2 Global Brigatinib API Consumption Value by Application (2021-2032)
  • 6.3 Global Brigatinib API Average Price by Application (2021-2032)

7 North America

  • 7.1 North America Brigatinib API Sales Quantity by Type (2021-2032)
  • 7.2 North America Brigatinib API Sales Quantity by Application (2021-2032)
  • 7.3 North America Brigatinib API Market Size by Country
    • 7.3.1 North America Brigatinib API Sales Quantity by Country (2021-2032)
    • 7.3.2 North America Brigatinib API Consumption Value by Country (2021-2032)
    • 7.3.3 United States Market Size and Forecast (2021-2032)
    • 7.3.4 Canada Market Size and Forecast (2021-2032)
    • 7.3.5 Mexico Market Size and Forecast (2021-2032)

8 Europe

  • 8.1 Europe Brigatinib API Sales Quantity by Type (2021-2032)
  • 8.2 Europe Brigatinib API Sales Quantity by Application (2021-2032)
  • 8.3 Europe Brigatinib API Market Size by Country
    • 8.3.1 Europe Brigatinib API Sales Quantity by Country (2021-2032)
    • 8.3.2 Europe Brigatinib API Consumption Value by Country (2021-2032)
    • 8.3.3 Germany Market Size and Forecast (2021-2032)
    • 8.3.4 France Market Size and Forecast (2021-2032)
    • 8.3.5 United Kingdom Market Size and Forecast (2021-2032)
    • 8.3.6 Russia Market Size and Forecast (2021-2032)
    • 8.3.7 Italy Market Size and Forecast (2021-2032)

9 Asia-Pacific

  • 9.1 Asia-Pacific Brigatinib API Sales Quantity by Type (2021-2032)
  • 9.2 Asia-Pacific Brigatinib API Sales Quantity by Application (2021-2032)
  • 9.3 Asia-Pacific Brigatinib API Market Size by Region
    • 9.3.1 Asia-Pacific Brigatinib API Sales Quantity by Region (2021-2032)
    • 9.3.2 Asia-Pacific Brigatinib API Consumption Value by Region (2021-2032)
    • 9.3.3 China Market Size and Forecast (2021-2032)
    • 9.3.4 Japan Market Size and Forecast (2021-2032)
    • 9.3.5 South Korea Market Size and Forecast (2021-2032)
    • 9.3.6 India Market Size and Forecast (2021-2032)
    • 9.3.7 Southeast Asia Market Size and Forecast (2021-2032)
    • 9.3.8 Australia Market Size and Forecast (2021-2032)

10 South America

  • 10.1 South America Brigatinib API Sales Quantity by Type (2021-2032)
  • 10.2 South America Brigatinib API Sales Quantity by Application (2021-2032)
  • 10.3 South America Brigatinib API Market Size by Country
    • 10.3.1 South America Brigatinib API Sales Quantity by Country (2021-2032)
    • 10.3.2 South America Brigatinib API Consumption Value by Country (2021-2032)
    • 10.3.3 Brazil Market Size and Forecast (2021-2032)
    • 10.3.4 Argentina Market Size and Forecast (2021-2032)

11 Middle East & Africa

  • 11.1 Middle East & Africa Brigatinib API Sales Quantity by Type (2021-2032)
  • 11.2 Middle East & Africa Brigatinib API Sales Quantity by Application (2021-2032)
  • 11.3 Middle East & Africa Brigatinib API Market Size by Country
    • 11.3.1 Middle East & Africa Brigatinib API Sales Quantity by Country (2021-2032)
    • 11.3.2 Middle East & Africa Brigatinib API Consumption Value by Country (2021-2032)
    • 11.3.3 Turkey Market Size and Forecast (2021-2032)
    • 11.3.4 Egypt Market Size and Forecast (2021-2032)
    • 11.3.5 Saudi Arabia Market Size and Forecast (2021-2032)
    • 11.3.6 South Africa Market Size and Forecast (2021-2032)

12 Market Dynamics

  • 12.1 Brigatinib API Market Drivers
  • 12.2 Brigatinib API Market Restraints
  • 12.3 Brigatinib API Trends Analysis
  • 12.4 Porters Five Forces Analysis
    • 12.4.1 Threat of New Entrants
    • 12.4.2 Bargaining Power of Suppliers
    • 12.4.3 Bargaining Power of Buyers
    • 12.4.4 Threat of Substitutes
    • 12.4.5 Competitive Rivalry

13 Raw Material and Industry Chain

  • 13.1 Raw Material of Brigatinib API and Key Manufacturers
  • 13.2 Manufacturing Costs Percentage of Brigatinib API
  • 13.3 Brigatinib API Production Process
  • 13.4 Industry Value Chain Analysis

14 Shipments by Distribution Channel

  • 14.1 Sales Channel
    • 14.1.1 Direct to End-User
    • 14.1.2 Distributors
  • 14.2 Brigatinib API Typical Distributors
  • 14.3 Brigatinib API Typical Customers

15 Research Findings and Conclusion

    16 Appendix

    • 16.1 Methodology
    • 16.2 Research Process and Data Source

    According to our (Global Info Research) latest study, the global Brigatinib API market size was valued at US$ million in 2025 and is forecast to a readjusted size of US$ million by 2032 with a CAGR of %during review period.
    Brigatinib is an active pharmaceutical ingredient (API) used for the treatment of non-small cell lung cancer (NSCLC) with ALK gene mutations.It is a selective ALK inhibitor that works by blocking the ALK protein.
    This report is a detailed and comprehensive analysis for global Brigatinib API market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
    Key Features:
    Global Brigatinib API market size and forecasts, in consumption value ($ Million), sales quantity (kg), and average selling prices (US$/kg), 2021-2032
    Global Brigatinib API market size and forecasts by region and country, in consumption value ($ Million), sales quantity (kg), and average selling prices (US$/kg), 2021-2032
    Global Brigatinib API market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (kg), and average selling prices (US$/kg), 2021-2032
    Global Brigatinib API market shares of main players, shipments in revenue ($ Million), sales quantity (kg), and ASP (US$/kg), 2021-2026
    The Primary Objectives in This Report Are:
    To determine the size of the total market opportunity of global and key countries
    To assess the growth potential for Brigatinib API
    To forecast future growth in each product and end-use market
    To assess competitive factors affecting the marketplace
    This report profiles key players in the global Brigatinib API market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Dr. Reddy’s Laboratories, Vitasv Pharma And Chemical, LGC, Cayman Chemical, Conscientia Industrial, Manus Aktteva Biopharma LLP, Selleck, Shandong Sihuan Pharmaceutical, Anqing benro Pharmaceutical, Vasudha Pharma, etc.
    This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
    Market Segmentation
    Brigatinib API market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
    Market segment by Type
    Purity≥99%
    Purity<99%
    Market segment by Application
    Online Sales
    Offline Sales
    Major players covered
    Dr. Reddy’s Laboratories
    Vitasv Pharma And Chemical
    LGC
    Cayman Chemical
    Conscientia Industrial
    Manus Aktteva Biopharma LLP
    Selleck
    Shandong Sihuan Pharmaceutical
    Anqing benro Pharmaceutical
    Vasudha Pharma
    Hefei Home Sunshine Pharmaceutical Technology
    Sandoo Pharmaceuticals and Chemicals
    Market segment by region, regional analysis covers
    North America (United States, Canada, and Mexico)
    Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
    Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
    South America (Brazil, Argentina, Colombia, and Rest of South America)
    Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
    The content of the study subjects, includes a total of 15 chapters:
    Chapter 1, to describe Brigatinib API product scope, market overview, market estimation caveats and base year.
    Chapter 2, to profile the top manufacturers of Brigatinib API, with price, sales quantity, revenue, and global market share of Brigatinib API from 2021 to 2026.
    Chapter 3, the Brigatinib API competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
    Chapter 4, the Brigatinib API breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2021 to 2032.
    Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2021 to 2032.
    Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2021 to 2026.and Brigatinib API market forecast, by regions, by Type, and by Application, with sales and revenue, from 2027 to 2032.
    Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
    Chapter 13, the key raw materials and key suppliers, and industry chain of Brigatinib API.
    Chapter 14 and 15, to describe Brigatinib API sales channel, distributors, customers, research findings and conclusion.

    Buy now